首页> 外国专利> Pyrrolopyrimidinone carboxamide derivatives, inhibiting CDK or pharmaceutically acceptable salts thereof and pharmaceutical composition for prevention or treatment of the apoptosis in hepatocellular carcinoma cells as an active ingredient

Pyrrolopyrimidinone carboxamide derivatives, inhibiting CDK or pharmaceutically acceptable salts thereof and pharmaceutical composition for prevention or treatment of the apoptosis in hepatocellular carcinoma cells as an active ingredient

机译:吡咯并嘧啶酮酮酰胺衍生物,抑制性CDK或其药学上可接受的盐以及用于预防或治疗肝癌细胞凋亡的药物组合物作为有效成分

摘要

PURPOSE: A pharmaceutical composition containing pyrrolopyrimidinone carboxamide derivative is provided to suppress Cdk1 and Cdk2 and to induce apoptosis of cancer cells. CONSTITUTION: A pyrrolopyrimidinone carboxamide derivative is denoted by chemical formula 1. A method for preparing the derivative comprises: a step of BSA to a compound of chemical formula 2 and adding a compound of chemical formula 3 under the presence of TMSOTf to prepare a compound of chemical formula 4; a step of adding ammonium hydroxide solution to the compound of chemical formula 4 to prepare a compound of chemical formula 5; and a step of adding hydrogen peroxide to the compound of chemical formula 5.
机译:目的:提供一种含有吡咯并嘧啶酮羧酰胺衍生物的药物组合物,以抑制Cdk1和Cdk2并诱导癌细胞凋亡。组成:一种吡咯并嘧啶酮酮羧酰胺衍生物,用化学式1表示。该衍生物的制备方法包括:将BSA加到化学式2的化合物中,并在TMSOTf存在下加入化学式3的化合物,以制备化学式1的化合物。化学式4;将氢氧化铵溶液加入化学式4的化合物中制备化学式5的化合物的步骤;将过氧化氢加到化学式5的化合物中的步骤

著录项

  • 公开/公告号KR101198302B1

    专利类型

  • 公开/公告日2012-11-07

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20100108193

  • 发明设计人 이승기;김병문;조승주;김영종;

    申请日2010-11-02

  • 分类号C07H19/14;A61K31/7064;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 17:07:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号